profit from every $100 of sales.
$0$100
Gedeon Richter
$40.70-1.10% today
+40.4% in 1 year
1-year low $29.001-year high $45.28
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $10.57 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Gedeon Richter sold, what it kept, and what it did with the cash.
Sales went from HUF 803 billion in 2022 to HUF 929 billion in 2025, with HUF 232 billion of profit last year.
SalesProfit
Gedeon Richter handed back 45% of the cash it generated last year.
HUF 93.1B
Free cash flow 2025HUF 210.0B
Bought back its own sharesHUF 2.0B
Paid as dividendsHUF 93.1B
Cash vs. debtHUF 211.8B vs. HUF 26.1B
Gedeon Richter vs. similar companies
Gedeon Richter grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Gedeon Richter | 10.6× · Cheap | ||
 Merck KGaA | 24.9× · Fair price | ||
 Takeda Pharmaceutical | 102.5× · Very expensive | ||
 Galderma Group | 86.9× · Very expensive | ||
 Teva Pharmaceutical Industries | 36.8× · Expensive |
AI analysis
An AI analyst reads Gedeon Richter's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of HUF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 802,755 | 805,158 | 857,545 | 928,962 | |
| 460,464 | 521,324 | 590,738 | 640,911 | |
| 203,005 | 246,361 | 270,497 | 326,935 | |
| 222,262 | 237,688 | 345,806 | 355,735 | |
| 169,076 | 158,850 | 239,244 | 232,335 | |
| 907.00 | 860.00 | 1,307.00 | 1,271.00 | |
| 57.4% | 64.7% | 68.9% | 69.0% | |
| 25.3% | 30.6% | 31.5% | 35.2% | |
| 21.1% | 19.7% | 27.9% | 25.0% |
Balance sheet
| In millions of HUF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1,353,784 | 1,361,217 | 1,607,241 | 1,698,220 |
| Cash | 79,719 | 80,493 | 135,627 | 211,817 |
| Total debt | 22,378 | 24,850 | 27,425 | 26,082 |
| Total liabilities | 279,937 | 218,636 | 303,379 | 297,331 |
| 1,063,401 | 1,130,814 | 1,300,462 | 1,398,394 | |
| 186 | 185 | 183 | 183 | |
| 12.6% | 12.8% | 17.4% | 16.4% | |
| 15.9% | 14.0% | 18.4% | 16.6% |
Cash flow
| In millions of HUF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 185,996 | 123,670 | 279,369 | 276,403 | |
| 71,579 | 94,639 | 63,718 | 66,404 | |
| 114,417 | 29,031 | 215,651 | 209,999 | |
| Dividends paid | 42,146 | 72,863 | 79,079 | 93,074 |
| 1,326 | 29,799 | 6,937 | 1,988 | |
| 1,552 | – | – | – |
Valuation
- 10.6×
- –
- 0.89
- 1.5×
- 2.6×
- 11.7×
- 6.4×
- 8.6%
- 9.5%
- 3.8%
Profitability
- 69.0%
- 35.2%
- 25.0%
- –
- 16.8%
- 15.2%
- –
- –
- –
- –
Growth
- +5.0%
- +11.9%
- –
- –
- −0.6%
Financial health
- -0.5×
- 0.02
- –
- 28.1×
- 4.37
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 13%of 963
Top 6%of 894
Top 11%of 632
Bottom 30%of 908
Top 11%of 991
3.8%of the share price, paid each year
On $1,000 invested$38a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
40.1% of its profit
Room to growStretchedMore than it earns: 44.3%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
7/7Passes 7 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
88Pass
Benjamin Graham
90Pass
Philip Fisher
82Pass
Peter Lynch
68Pass
Joel Greenblatt
63Pass
Charlie Munger
82Pass
Terry Smith
72Pass
Questions about Gedeon Richter
Is Gedeon Richter a good stock to buy?
A strong, very profitable business, and the price looks low. 7 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Gedeon Richter AI analysis
What does Gedeon Richter do?
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It is in Drug Manufacturers - Specialty & Generic, based in Budapest, Hungary, with 11,155 employees.
Does Gedeon Richter pay a dividend?
Yes. At today's price the dividend is 3.8% a year, about 40% of its yearly profit. In 2025 it paid out $93.1 billion in dividends.
Is Gedeon Richter stock halal?
Yes. Gedeon Richter passes our halal screen: its business is permitted and its debt is 1% of its market value, under the 30% limit. How we check
How has Gedeon Richter stock done over the past year?
Up 40.4% over the past twelve months, to $40.70. It traded between $29.00 and $45.28 and is 10.1% below its high.
Who are Gedeon Richter's competitors?
The largest listed companies in the same industry are Merck KGaA, Takeda Pharmaceutical, Galderma Group and Teva Pharmaceutical Industries. The peers table on this page compares their profit, growth and price with Gedeon Richter's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.